-
PUBLIC PREFERENCES FOR LUNG NODULE BIOPSY AHEAD OF NATIONAL LUNG CANCER SCREENING: A UK DISCRETE CHOICE EXPERIMENT
Aug 25, 2026, 15:56 PM -
QUALITY OF LIFE VERSUS LENGTH OF LIFE: PREFERENCES OF CANCER PATIENTS FROM EIGHT EUROPEAN COUNTRIES
Aug 25, 2026, 15:56 PM -
PREFERENCES FOR TARGETED THERAPY ATTRIBUTES AMONG CHINESE PATIENTS WITH ALK-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER: A DISCRETE CHOICE EXPERIMENT
Aug 25, 2026, 15:56 PM -
GOVERNANCE AND SAFEGUARDS TO EVALUATE GENERATIVE AI TOOLS AT NICE
Aug 25, 2026, 15:56 PM -
CAN GENERATIVE AI RELIABLY IDENTIFY PAYER DECISIONS AND REPLACE MANUAL HTA REVIEW? A COMPARISON OF AI AND HUMAN EXTRACTION OF A FRENCH HTA REPORT
Aug 25, 2026, 15:56 PM -
SCALING RARE DISEASE INSIGHTS THROUGH AI-DRIVEN PHENOTYPE SEARCH ON FEDERATED NETWORKS
Aug 25, 2026, 15:56 PM -
VALIDATION OF A GENERAL-PURPOSE AI AGENT (CLAUDE) FOR KAPLAN-MEIER CURVE DIGITIZATION AND PARAMETRIC SURVIVAL EXTRAPOLATION
Aug 25, 2026, 15:56 PM -
ARE APPROVED THERAPIES ALWAYS THE MOST RELEVANT COMPARATORS? A LIVING EVIDENCE ANALYSIS OF REGULATORY-GUIDELINE-REIMBURSEMENT DIVERGENCE ACROSS SIX ONCOLOGY INDICATIONS
Aug 25, 2026, 15:55 PM -
EVIDENCE GAPS AND STRATEGIC LESSONS FROM THE TOVORAFENIB CASE - A CRITICAL APPRAISAL OF FIRST EU JCA REPORT
Aug 25, 2026, 15:55 PM -
HOW MANY PICOS CAN ONE ASSESSMENT CARRY? SCOPE AND FEASIBILITY IN EU JOINT CLINICAL ASSESSMENT
Aug 25, 2026, 15:55 PM -
METHODOLOGICAL FIT BETWEEN THE EU JOINT CLINICAL ASSESSMENT AND EVIDENCE GENERATION FOR ADVANCED THERAPY AND ORPHAN MEDICINES
Aug 25, 2026, 15:55 PM -
CRITICAL ANALYSIS OF THE HISTORY AND IMPACT OF COST-EFFECTIVENESS THRESHOLDS: LESSONS AND INSIGHTS FOR DECISION-MAKERS
Aug 25, 2026, 15:55 PM -
READINESS OF HEALTH TECHNOLOGY DEVELOPERS FOR EU JOINT CLINICAL ASSESSMENT: EVIDENCE REQUIREMENTS, OPERATIONAL CHALLENGES, AND NATIONAL HTA IMPLICATIONS
Aug 25, 2026, 15:55 PM -
REAL-WORLD DATA FOR MEDICAL DEVICE ARTIFICIAL INTELLIGENCE: A EUROPEAN HTA BODIES SURVEY
Aug 25, 2026, 15:55 PM -
EXAMINING HOW HEALTH EQUITY IS CONSIDERED IN HEALTH TECHNOLOGY ASSESSMENT: AN ANALYSIS OF DOCUMENTS FROM FOUR BODIES
Aug 25, 2026, 15:55 PM -
EXTENDING MULTILEVEL NETWORK META-REGRESSION TO UNANCHORED NETWORKS AND SINGLE-ARM STUDIES
Aug 25, 2026, 15:55 PM -
FORWARD-LOOKING PICO: A PRIORITIZATION AND OPTIMIZATION FRAMEWORK TO SUPPORT GLOBAL HTA STRATEGY IN THE ERA OF JOINT CLINICAL ASSESSMENTS
Aug 25, 2026, 15:55 PM -
INDIRECT TREATMENT COMPARISON FEASIBILITY ASSESSMENTS IN HEALTH TECHNOLOGY SUBMISSIONS: A REVIEW OF NICE TECHNOLOGY APPRAISALS
Aug 25, 2026, 15:55 PM -
THE PRISMA-ECONEVAL 2026 STATEMENT: EXTENSION OF PRISMA AS A REPORTING GUIDELINE FOR SYSTEMATIC REVIEWS OF HEALTH ECONOMIC EVALUATIONS
Aug 25, 2026, 15:55 PM -
WHEN THE TAIL WAGS THE DOG III: A PERSIST-VERSUS-FADE EXTRAPOLATION CHOICE AND THE SURVIVAL RATIO SHIFT (RASOLUTE302)
Aug 25, 2026, 15:55 PM
